Latest filing published 23 Oct 2023 for Ayala Pharmaceuticals, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of aMoon Growth Fund Limited Partnership across 3 companies, led by Seer, Inc., Ayala Pharmaceuticals, Inc. and Old Ayala, Inc. We count 4 filings; the first trade dates from 9 June 2021 and the latest from 18 October 2023.
The open-market record consists of 2 sales worth €24.6M, with no purchase.
The record was last updated on 23 October 2023 with a transaction in Ayala Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations